MATRIXOME, Inc.
PrivateLast Round
Seed
Jan 29, 2016
Est. Valuation
$6.54M
Total Funding Raised
$2.32M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MATRIXOME, Inc. is a biotechnology company that develops, produces, and distributes extracellular matrix (ECM) proteins, specifically recombinant laminin E8 fragments, for use in stem cell research and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MATRIXOME, Inc. Comparables
Compare MATRIXOME, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioLamina AB | 84% | |
| Sartorius Aktiengesellschaft | 72% | |
| Corning | 71% | |
MATRIXOME, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 29, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 48% MoM.
- Jan 20, 2026
Monthly visitors increased 73% MoM.
MATRIXOME, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MATRIXOME, Inc.'s valuation, stock price, and market status.